The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Horowitz Zebulun D since year 2005.
The trader's CIK number is 1225436.
At the time of this reporting, Horowitz Zebulun D is the SVP, Chief Medical Officer of Savient Pharmaceuticals Inc .
(stock ticker symbol SVNT).
See this page for all insider trading activities at Savient Pharmaceuticals Inc .
Stock purchases, sales, and option exercises reported by insider Horowitz Zebulun D since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-04-14
SVNT
Savient Pharmaceuticals Inc
Sale
3,785
19.05
72,094
2008-02-15
SVNT
Savient Pharmaceuticals Inc
Sale
4,403
19.95
87,844
2008-02-01
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
19.56
97,791
2008-02-04
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
4.31
21,549
2008-02-04
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
19.86
99,306
2008-02-01
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-22
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
20.21
101,061
2008-01-22
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-18
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
20.67
103,336
2008-01-18
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-17
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-15
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
21.46
107,302
2008-01-16
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-15
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-17
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
20.44
102,198
2008-01-16
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
20.64
103,218
2008-01-10
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-11
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-10
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
21.93
109,652
2008-01-11
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
22.02
110,079
2008-01-14
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-14
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
21.77
108,845
2008-01-09
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
21.59
107,967
2008-01-08
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
23.15
115,727
2008-01-09
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-07
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
23.00
115,025
2008-01-08
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-07
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-03
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
24.25
121,226
2008-01-04
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-02
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
23.47
117,340
2008-01-03
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-02
SVNT
Savient Pharmaceuticals Inc
Option Exercise
5,000
2.52
12,600
2008-01-04
SVNT
Savient Pharmaceuticals Inc
Sale
5,000
23.26
116,320
2007-12-10
SVNT
Savient Pharmaceuticals Inc
Sale
6,046
15.31
92,588
2007-04-12
SVNT
Savient Pharmaceuticals Inc
Sale
3,805
12.01
45,707
2007-03-05
SVNT
Savient Pharmaceuticals Inc
Sale
18,942
12.50
236,775
2007-02-15
SVNT
Savient Pharmaceuticals Inc
Sale
2,517
14.47
36,411
2006-04-12
SVNT
Savient Pharmaceuticals Inc
Sale
6,159
5.87
36,153
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Horowitz Zebulun D
(SVP, Chief Medical Officer of Savient Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
